Clinical Trials Sponsored by ICTS BJH

Total 126 results

Washington University School of Medicine
ICTS BJH; Center for Diabetes Translation Research

Completed

Safety and Feasibility of a Low Carbohydrate Diet in Children With Type 1 Diabetes

Type 1 Diabetes

United States
Thuasne
RCTs

Recruiting

Lumbar Belt Benefit Compared to the Usual Care in the Treatment of Non-specific Low Back Pain (LOMBACT)

Low Back Pain

France
ICOS Corporation

Completed

A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Pneumonia | Sepsis

United States
ICOS Corporation

Completed

Interstitial Cystitis

Interstitial Cystitis

United States
ICOS-Texas Biotechnology
ICOS Corporation; Texas Biotechnology Corporation

Unknown

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States, Canada
J Ints Bio

Recruiting

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

EGFR Mutant Advanced Non-small Cell Lung Cancer

Korea, Republic of, United States, Thailand
Lohmann & Rauscher
RCTs

Completed

Comparative Evaluation of the propertieS of the Contact LAyer Dressing LOMatuell Pro® Versus UrgoTul® in the Management of Acute Wounds (SLALOM)

Acute Wounds

France
J Ints Bio

Withdrawn

Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Malignancies (MPT0B64)

Advanced Solid Tumor | Metastatic Solid Tumor
J Ints Bio

Withdrawn

Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection

Covid19
Azitra Inc.
RCTs

Completed

Safety Study of AZT-04 for Cosmetic Use

Study of Three Doses of AZT-04 for Skin Appearance

United States
INRESA Pharma
RCTs

Completed

The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study) (ADHOC)

Foot Ulcer, Diabetic

France, Czechia, Poland
ICOS Corporation
Suntory Pharmaceutical

Terminated

Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis

Sepsis

United States
ICLS Dermatology & Plastic Surgery

Completed

Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study

Facial Rhytids
BDH-Klinik Hessisch Oldendorf

Recruiting

Effectiveness of Music Therapy on Level of Consciousness

Traumatic Brain Injury | Neurologic Disorder | Disorder of Consciousness

Germany
BDH-Klinik Hessisch Oldendorf

Recruiting

Influence of the Body Composition of Neurological (Early) Rehabilitants on Rehabilitation Success

Neurological Rehabilitation

Germany
BDH-Klinik Hessisch Oldendorf

Completed

Weaning Success in Different Weaning Strategies in Early Neurological Rehabilitation Patients - a Matched-pair Analysis

Respiratory Insufficiency | Neurologic Disorder

Germany
BDH-Klinik Hessisch Oldendorf

Completed

Effectiveness of YNSA Acupuncture on Brain Networks

Acupuncture

Germany
BDH-Klinik Hessisch Oldendorf

Recruiting

Magnesium and Cognition After Stroke

Stroke | Neurologic Disorder | Cognition | Magnesium

Germany
BDH-Klinik Hessisch Oldendorf

Recruiting

Hippocampal Volume and Memory Functions in Aneurysmal Subarachnoid Hemorrhage

Neurologic Disorder | Subarachnoid Hemorrhage, Aneurysmal

Germany
BDH-Klinik Hessisch Oldendorf

Recruiting

Prognostic Factors to Regain Consciousness

Stroke | Traumatic Brain Injury | Neurologic Disorder | Disorder of Consciousness | Hypoxic-Ischemic Encephalopathy

Germany
BDH-Klinik Hessisch Oldendorf

Active, not recruiting

Effects of ASMR on the Default Mode Network

Autonomous Sensory Meridian Response | Audiobook

Germany
BDH-Klinik Hessisch Oldendorf

Withdrawn

rTMS as an add-on Therapy in Patients With Post-stroke Depression

Post-stroke Depression

Germany
REGEnLIFE SAS
University Hospital, Montpellier; RCTs

Completed

Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome (RECOVERY)

Acute Concussion Syndrome

France
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Hypertension, Pulmonary

United States, Belgium, Canada, France, Germany, Ireland, Italy, Japan, Spain, United Kingdom
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Eli Lilly and Company
ICOS Corporation

Completed

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

France, United States, Italy
Eli Lilly and Company
ICOS Corporation

Completed

A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

Impotence

United Kingdom
Eli Lilly and Company
ICOS Corporation

Completed

Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

Impotence

Brazil
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems (PILUTS)

Prostatic Hyperplasia | Prostate

United States
REGEnLIFE SAS
University Hospital, Toulouse; RCTs

Recruiting

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease (LIGHT4LIFE)

Alzheimer Disease

France
Fundacio Ictus Malaltia Vascular
Medtronic - MITG

Terminated

Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours (REVASCAT)

Acute Stroke

Spain
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

Impotence

United States, Austria, France, Germany, Mexico
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying

Gastroparesis

Canada
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil in Subjects With Mild to Moderate Hypertension

Hypertension

United States
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg

Erectile Dysfunction

United States
Wynand BWH Melenhorst, MD

Completed

Efficacy of Arnica D1 Ointment After Upper Blepharoplasty (ARINE)

Blepharoplasty | Upper Eyelid Blepharoplasty

Netherlands
Rogers, B.H. Gerald, M.D.
3M

Terminated

Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus

Barrett Esophagus

United States
Cork University Maternity Hospital
HealthBeacon ICMS

Recruiting

LMWH Compliance in Pregnancy

Venous Thromboembolism | Antenatal Deep Vein Thrombosis

Ireland
Eli Lilly and Company
ICOS Corporation

Completed

Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Greece, Portugal
Eli Lilly and Company
ICOS Corporation

Completed

Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction

Erectile Dysfunction | Impotence

Finland
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

Erectile Dysfunction | Spinal Cord Injuries

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Impotence

Korea, Republic of
Eli Lilly and Company
ICOS Corporation

Completed

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Impotence

China
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Impotence

Germany
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Impotence

Japan
Eli Lilly and Company
ICOS Corporation

Completed

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Impotence

Sweden

Clinical Trials Sponsored by ICTS BJH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations